Prognostic Significance of Expression of VEGF and Cox-2 in Nasopharyngeal Carcinoma and Its Association With Expression of C-erbB2 and EGFR

被引:28
|
作者
Kim, Tae-Jung [1 ]
Lee, Youn Soo [1 ]
Kang, Jin-Hyung [2 ]
Kim, Yeon-Sil [3 ]
Kang, Chang Suk [1 ]
机构
[1] Catholic Univ Korea, Dept Hosp Pathol, Coll Med, Seoul, South Korea
[2] Catholic Univ Korea, Div Med Oncol, Dept Internal Med, Coll Med, Seoul, South Korea
[3] Catholic Univ Korea, Dept Radiat Oncol, Coll Med, Seoul, South Korea
关键词
nasopharyngeal carcinoma; VEGF; Cox-2; C-erbB2; EGFR; GROWTH-FACTOR-RECEPTOR; SQUAMOUS-CELL CARCINOMA; EPSTEIN-BARR-VIRUS; CYCLOOXYGENASE-2; EXPRESSION; TUMOR ANGIOGENESIS; TREATMENT OUTCOMES; BREAST-CANCER; SURVIVAL; RADIOTHERAPY; COEXPRESSION;
D O I
10.1002/jso.21767
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objectives: This study evaluated several tumor angiogenesis-related markers to examine their expression pattern and relation to clinicopathologic implications of nasopharyngeal carcinoma. Methods: Paraffin sections from 69 nasopharyngeal carcinomas obtained before radiotherapy were prepared. The expression of vascular endothelial growth factor (VEGF), cyclooxygenase-2 (Cox-2), C-erbB2, and epidermal growth factor receptor (EGFR) were investigated by immunohistochemistry and then correlated with various clinicopathologic parameters. Results: VEGF was inversely correlated with C-erbB2 (P = 0.036). In survival analysis, high mitosis (>= 5/10 high power field) was significantly associated with worse relapse-free survival in univariate analysis (P = 0.048) but not in multivariate analysis (P = 0.153). High stage, high mitotic rate, absence of VEGF, and presence of Cox-2 were associated with worse survival in both univariate analysis (P = 0.002, P = 0.038, P = 0.044, and P = 0.028, respectively) and multivariate analysis (P = 0.007, P = 0.036, P = 0.047, and P = 0.004, respectively). Conclusions: Absence of VEGF is a useful indicator of poor prognosis in addition to Cox-2 expression, high stage, and high mitosis. J. Surg. Oncol. 2011; 103: 46-52. (c) 2010 Wiley-Liss, Inc.
引用
收藏
页码:46 / 52
页数:7
相关论文
共 50 条
  • [41] Cox-2 Expression in Malignant Breast Tumors
    An, Min-Sung
    Kim, Sang-Hyo
    Yoon, Hye-Kyoung
    Kim, Woon-Won
    JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2009, 77 (06): : 371 - 377
  • [42] PTGS2 (COX-2) -765 G>C functional promoter polymorphism and its association with risk and lymph node metastasis in nasopharyngeal carcinoma
    Ben Nasr, Hela
    Chahed, Karim
    Bouaouina, Noureddine
    Chouchane, Lotfi
    MOLECULAR BIOLOGY REPORTS, 2009, 36 (01) : 193 - 200
  • [43] Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer
    Bayrak, Muharrem
    Olmez, Omer Fatih
    Kurt, Ender
    Cubukcu, Erdem
    Evrensel, Turkkan
    Kanat, Ozkan
    Manavoglu, Osman
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (04) : 307 - 312
  • [44] COX-2 expression and outcome in canine nasal carcinomas treated with hypofractionated radiotherapy
    Belshaw, Z.
    Constantio-Casas, F.
    Brearley, M. J.
    Dunning, M. D.
    Holmes, M. A.
    Dobson, J. M.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2011, 9 (02) : 141 - 148
  • [45] EXPRESSION OF iNOS, COX-2 AND VEGF IN CANINE MAMMARY TUMOURS AND NON-NEOPLASTIC MAMMARY GLANDS: ASSOCIATION WITH CLINICOPATHOLOGICAL FEATURES AND TUMOUR GRADE
    Anadol, Elvan
    Yar Saglam, Atiye Seda
    Gultiken, Nilgun
    Karakas, Kubra
    Alcigir, Eray
    Alkan, Hasan
    Kanca, Halit
    ACTA VETERINARIA HUNGARICA, 2017, 65 (03) : 382 - 393
  • [46] Prognostic significance of the co-expression of EGFR and HER2 in adenocarcinoma of the uterine cervix
    Ueda, Asako
    Takasawa, Akira
    Akimoto, Taishi
    Takasawa, Kumi
    Aoyama, Tomoyuki
    Ino, Yoshihiko
    Nojima, Masanori
    Ono, Yusuke
    Murata, Masaki
    Osanai, Makoto
    Hasegawa, Tadashi
    Saito, Tsuyoshi
    Sawada, Norimasa
    PLOS ONE, 2017, 12 (08):
  • [47] Tristetraprolin Downregulates the Expression of Both VEGF and COX-2 in Human Colon Cancer
    Cha, Hee Jeong
    Lee, Hyun Hee
    Chae, Seoung Wan
    Cho, Wha Ja
    Kim, Young Min
    Choi, Hye-Jeong
    Choi, Dae Hwa
    Jung, Seok Won
    Min, Young Joo
    Lee, Byung Ju
    Park, Soon Eun
    Park, Jeong Woo
    HEPATO-GASTROENTEROLOGY, 2011, 58 (107) : 790 - 795
  • [48] Role of C-erbB2 expression in gallbladder cancer
    Kumari, Niraj
    Kapoor, V. K.
    Krishnani, Narendra
    Kumar, Kamlesh
    Baitha, Dinesh Kumar
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2012, 55 (01) : 75 - 79
  • [49] Expression of COX-2, MMP-2 and VEGF in Stage II and III Colorectal Cancer and the Clinical Significance
    Peng Zhi-Heng
    Wan De-Sen
    Li Li-Ren
    Chen Gong
    Lu Zhen-Hai
    Wu Xiao-Jun
    Kong Ling-Heng
    Pan Zhi-Zhong
    HEPATO-GASTROENTEROLOGY, 2011, 58 (106) : 369 - 376
  • [50] Lack of Prognostic Significance of C-erbB-2 Expression in Low- and High- grade Astrocytomas
    Muallaoglu, Sadik
    Besen, Ali Ayberk
    Ata, Alper
    Mertsoylu, Huseyin
    Arican, Ali
    Kayaselcuk, Fazilet
    Ozyilkan, Ozgur
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (03) : 1333 - 1337